CERS - Cerus Corporation

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Cerus GAAP EPS of -$0.09 misses by $0.01, revenue of $38.48M beats by $1.47M
• Cerus Q1 2023 Earnings Preview
• Cerus GAAP EPS of -$0.08 misses by $0.02, product revenue of $44.03M beats by $0.56M
• Cerus sheds 19% after issuing 2023 guidance
• Cerus GAAP EPS of -$0.05 beats by $0.01, revenue of $46.34M beats by $6.22M
• Cerus Q3 2022 Earnings Preview
• Health Canada approves extended shelf life for Cerus' blood system treated platelets
• Cerus GAAP EPS of -$0.05 beats by $0.02, revenue of $47.63M beats by $4.87M
• Cerus Q2 2022 Earnings Preview
• Cerus GAAP EPS of -$0.07 beats by $0.01, revenue of $43.02M beats by $5.53M
• Cerus Q1 2022 Earnings Preview
• Cerus signs new production & supply deal with Fresenius Kabi for INTERCEPT Blood System sets
• Cerus inks contract with American Red Cross for Intercept blood system for platelets
• Cerus GAAP EPS of -$0.05 beats by $0.03, revenue of $39.87M in-line
• Cerus Q4 2021 Earnings Preview
• Cerus expects record Q4 and FY21 revenue
• FDA updates EUA for COVID convalescent plasma limiting use to certain patients
• ICE Biotech index rejig: AUPH, AVXL among added; AMRS, GH among deleted
• Cerus up 17% following guidance raise, Q3 2021 earnings beat
• Cerus raises guidance ahead of consensus after strong revenue beat